S&P 500   4,591.67 (+1.17%)
DOW   35,227.03 (+1.87%)
QQQ   386.20 (+0.80%)
AAPL   165.32 (+2.15%)
MSFT   326.19 (+0.98%)
FB   317.87 (+3.59%)
GOOGL   2,863.10 (+0.81%)
AMZN   3,427.37 (+1.11%)
TSLA   1,009.01 (-0.59%)
NVDA   300.37 (-2.14%)
BABA   123.60 (+10.40%)
NIO   32.34 (+0.59%)
CGC   10.15 (+1.60%)
AMD   139.06 (-3.44%)
GE   96.01 (+3.49%)
MU   82.45 (+1.02%)
T   23.28 (-0.77%)
F   19.22 (+0.42%)
DIS   150.37 (+2.84%)
PFE   51.48 (-5.14%)
AMC   28.79 (-0.76%)
ACB   5.97 (+2.58%)
BA   205.88 (+3.72%)
S&P 500   4,591.67 (+1.17%)
DOW   35,227.03 (+1.87%)
QQQ   386.20 (+0.80%)
AAPL   165.32 (+2.15%)
MSFT   326.19 (+0.98%)
FB   317.87 (+3.59%)
GOOGL   2,863.10 (+0.81%)
AMZN   3,427.37 (+1.11%)
TSLA   1,009.01 (-0.59%)
NVDA   300.37 (-2.14%)
BABA   123.60 (+10.40%)
NIO   32.34 (+0.59%)
CGC   10.15 (+1.60%)
AMD   139.06 (-3.44%)
GE   96.01 (+3.49%)
MU   82.45 (+1.02%)
T   23.28 (-0.77%)
F   19.22 (+0.42%)
DIS   150.37 (+2.84%)
PFE   51.48 (-5.14%)
AMC   28.79 (-0.76%)
ACB   5.97 (+2.58%)
BA   205.88 (+3.72%)
S&P 500   4,591.67 (+1.17%)
DOW   35,227.03 (+1.87%)
QQQ   386.20 (+0.80%)
AAPL   165.32 (+2.15%)
MSFT   326.19 (+0.98%)
FB   317.87 (+3.59%)
GOOGL   2,863.10 (+0.81%)
AMZN   3,427.37 (+1.11%)
TSLA   1,009.01 (-0.59%)
NVDA   300.37 (-2.14%)
BABA   123.60 (+10.40%)
NIO   32.34 (+0.59%)
CGC   10.15 (+1.60%)
AMD   139.06 (-3.44%)
GE   96.01 (+3.49%)
MU   82.45 (+1.02%)
T   23.28 (-0.77%)
F   19.22 (+0.42%)
DIS   150.37 (+2.84%)
PFE   51.48 (-5.14%)
AMC   28.79 (-0.76%)
ACB   5.97 (+2.58%)
BA   205.88 (+3.72%)
S&P 500   4,591.67 (+1.17%)
DOW   35,227.03 (+1.87%)
QQQ   386.20 (+0.80%)
AAPL   165.32 (+2.15%)
MSFT   326.19 (+0.98%)
FB   317.87 (+3.59%)
GOOGL   2,863.10 (+0.81%)
AMZN   3,427.37 (+1.11%)
TSLA   1,009.01 (-0.59%)
NVDA   300.37 (-2.14%)
BABA   123.60 (+10.40%)
NIO   32.34 (+0.59%)
CGC   10.15 (+1.60%)
AMD   139.06 (-3.44%)
GE   96.01 (+3.49%)
MU   82.45 (+1.02%)
T   23.28 (-0.77%)
F   19.22 (+0.42%)
DIS   150.37 (+2.84%)
PFE   51.48 (-5.14%)
AMC   28.79 (-0.76%)
ACB   5.97 (+2.58%)
BA   205.88 (+3.72%)
NYSE:CLS

Celestica Stock Forecast, Price & News

$10.67
+0.12 (+1.14%)
(As of 12/6/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.54
$10.87
50-Day Range
$8.88
$11.60
52-Week Range
$7.01
$11.88
Volume
343,799 shs
Average Volume
350,194 shs
Market Capitalization
$1.35 billion
P/E Ratio
14.62
Dividend Yield
N/A
Beta
2.4
30 days | 90 days | 365 days | Advanced Chart
Receive CLS News and Ratings via Email

Sign-up to receive the latest news and ratings for Celestica and its competitors with MarketBeat's FREE daily newsletter.


Celestica logo

About Celestica

Celestica, Inc. engages in the provision of supply chain solutions globally to original equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) business segments. The ATS segment comprises of aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. Celestica was founded in 1994 and is headquartered in Toronto, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Printed circuit boards
Sub-Industry
N/A
Employees
20,550
Year Founded
N/A

Sales & Book Value

Annual Sales
$5.75 billion
Cash Flow
$2.00 per share
Book Value
$11.59 per share

Profitability

Net Income
$60.60 million
Pretax Margin
2.19%

Debt

Price-To-Earnings

Miscellaneous

Free Float
125,530,000
Market Cap
$1.35 billion
Optionable
Optionable

Company Calendar

Last Earnings
10/24/2021
Today
12/06/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
1/25/2022

MarketRank

Overall MarketRank

1.95 out of 5 stars

Computer And Technology Sector

479th out of 894 stocks

Printed Circuit Boards Industry

9th out of 16 stocks

Analyst Opinion: 0.8Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 4.4 5 -4 -3 -2 -1 -












Celestica (NYSE:CLS) Frequently Asked Questions

Is Celestica a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Celestica in the last year. There are currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Celestica stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLS, but not buy additional shares or sell existing shares.
View analyst ratings for Celestica
or view top-rated stocks.

How has Celestica's stock been impacted by COVID-19?

Celestica's stock was trading at $5.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CLS shares have increased by 110.5% and is now trading at $10.67.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Celestica?

Celestica saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 577,800 shares, an increase of 57.9% from the October 31st total of 365,900 shares. Based on an average daily volume of 374,600 shares, the short-interest ratio is presently 1.5 days. Approximately 0.6% of the shares of the stock are short sold.
View Celestica's Short Interest
.

When is Celestica's next earnings date?

Celestica is scheduled to release its next quarterly earnings announcement on Tuesday, January 25th 2022.
View our earnings forecast for Celestica
.

How were Celestica's earnings last quarter?

Celestica Inc. (NYSE:CLS) issued its quarterly earnings results on Sunday, October, 24th. The technology company reported $0.35 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.32 by $0.03. The technology company had revenue of $1.47 billion for the quarter, compared to analysts' expectations of $1.48 billion. Celestica had a net margin of 1.67% and a trailing twelve-month return on equity of 9.96%. During the same quarter in the previous year, the firm posted $0.32 EPS.
View Celestica's earnings history
.

What guidance has Celestica issued on next quarter's earnings?

Celestica updated its fourth quarter 2021 earnings guidance on Wednesday, December, 1st. The company provided earnings per share guidance of $0.350-$0.410 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.320. The company issued revenue guidance of $1.43 billion-$1.58 billion, compared to the consensus revenue estimate of $1.49 billion.

What price target have analysts set for CLS?

3 equities research analysts have issued twelve-month target prices for Celestica's shares. Their forecasts range from $8.50 to $11.50. On average, they anticipate Celestica's stock price to reach $10.33 in the next twelve months. This suggests that the stock has a possible downside of 3.2%.
View analysts' price targets for Celestica
or view top-rated stocks among Wall Street analysts.

Who are Celestica's key executives?

Celestica's management team includes the following people:
  • Robert A. Mionis, President, CEO & Non-Independent Director
  • Todd C. Cooper, Chief Operations Officer
  • Mandeep Chawla, Chief Financial Officer
  • Jack Lawless, President-Advanced Technology Solutions
  • Leila Wong, Chief Human Resources Officer

What is Rob Mionis' approval rating as Celestica's CEO?

94 employees have rated Celestica CEO Rob Mionis on Glassdoor.com. Rob Mionis has an approval rating of 63% among Celestica's employees. This puts Rob Mionis in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Celestica own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Celestica investors own include Aurora Cannabis (ACB), Quantum (QTM), Ballard Power Systems (BLDP), Portland General Electric (POR), NVIDIA (NVDA), Shopify (SHOP), AT&T (T), Advanced Micro Devices (AMD), Walt Disney (DIS) and Freeport-McMoRan (FCX).

What is Celestica's stock symbol?

Celestica trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLS."

Who are Celestica's major shareholders?

Celestica's stock is owned by a variety of institutional and retail investors. Top institutional investors include Letko Brosseau & Associates Inc. (10.82%), Pzena Investment Management LLC (6.86%), Donald Smith & CO. Inc. (3.93%), Scheer Rowlett & Associates Investment Management Ltd. (3.12%), FIL Ltd (2.42%) and Arrowstreet Capital Limited Partnership (2.11%).

Which institutional investors are selling Celestica stock?

CLS stock was sold by a variety of institutional investors in the last quarter, including Connor Clark & Lunn Investment Management Ltd., Hillsdale Investment Management Inc., Letko Brosseau & Associates Inc., Deutsche Bank AG, TD Asset Management Inc., CIBC Asset Management Inc, Goldman Sachs Group Inc., and Pzena Investment Management LLC.

Which institutional investors are buying Celestica stock?

CLS stock was acquired by a variety of institutional investors in the last quarter, including Arrowstreet Capital Limited Partnership, FIL Ltd, Donald Smith & CO. Inc., SG Capital Management LLC, ClariVest Asset Management LLC, Two Sigma Investments LP, Renaissance Technologies LLC, and Royal Bank of Canada.

How do I buy shares of Celestica?

Shares of CLS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Celestica's stock price today?

One share of CLS stock can currently be purchased for approximately $10.67.

How much money does Celestica make?

Celestica has a market capitalization of $1.35 billion and generates $5.75 billion in revenue each year. The technology company earns $60.60 million in net income (profit) each year or $0.73 on an earnings per share basis.

How many employees does Celestica have?

Celestica employs 20,550 workers across the globe.

What is Celestica's official website?

The official website for Celestica is www.celestica.com.

Where are Celestica's headquarters?

Celestica is headquartered at 5140 YONGE STREET SUITE 1900, TORONTO A6, M2N 6L7.

How can I contact Celestica?

Celestica's mailing address is 5140 YONGE STREET SUITE 1900, TORONTO A6, M2N 6L7. The technology company can be reached via phone at (416) 448-2211, via email at [email protected], or via fax at 416-448-2280.


This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.